网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
肠道菌群失调在脂代谢紊乱介导的靶器官损害中的作用研究进展
作者:张佳修  马坤岭 
单位:东南大学附属中大医院 肾内科, 东南大学肾脏病研究所, 江苏 南京 210009
关键词:肠道菌群 脂代谢紊乱 靶器官损害 文献综述 
分类号:R363.14
出版年·卷·期(页码):2018·46·第七期(831-835)
摘要:

近年来研究发现,肠道菌群失调参与了脂代谢紊乱介导的靶器官损害相关性疾病。作者从影响肠道菌群构成的因素出发,分别对肠道菌群与脂代谢紊乱介导的肥胖、心血管疾病、肝损伤、肾损伤等疾病关系的研究进展进行综述,探求肠道菌群与脂代谢紊乱相关性疾病的关系,认为针对肠道菌群及其代谢产物进行干预可能是预防和医治脂代谢紊乱介导的靶器官损害的新措施。

参考文献:

[1] SENDER R,FUCHS S,MILO R.Revised estimates for the number of human and bacteria cells in the body[J].PLoS Biol,2016,14(8):e1002533.
[2] DONALDSON G P,LEE S M,MAZMANIAN S K.Gut biogeography of the bacterial microbiota[J].Nat Rev Microbiol,2016,14(1):20-32.
[3] LIU S,DA C A,REZENDE R M,et al.The host shapes the gut microbiota via fecal microRNA[J].Cell Host Microbe,2016,19(1):32-43.
[4] CULLEN T W,SCHOFIELD W B,BARRY N A,et al.Gut microbiota.antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation[J].Science,2015,347(6218):170-175.
[5] LEVIN B J,HUANG Y Y,PECK S C,et al.A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline[J].Science,2017,355(6325). pii:eaai8386.doi:10.1126/science.aai8386.
[6] YASSOUR M,VATANEN T,SILJANDER H,et al.Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability[J].Sci Transl Med,2016,8(343):343r-381r.
[7] RODRIGUEZ J M,MURPHY K,STANTON C,et al.The composition of the gut microbiota throughout life,with an emphasis on early life[J].Microb Ecol Health Dis,2015,26:26050.
[8] HALL A B,TOLONEN A C,XAVIER R J.Human genetic variation and the gut microbiome in disease[J].Nat Rev Genet,2017,18(11):690-699.
[9] DAVID L A,MAURICE C F,CARMODY R N,et al.Diet rapidly and reproducibly alters the human gut microbiome[J].Nature,2014,505(7484):559-563.
[10] GOODRICH J K,DAVENPORT E R,BEAUMONT M,et al.Genetic determinants of the gut microbiome in UK twins[J].Cell Host Microbe,2016,19(5):731-743.
[11] CARMODY R N,GERBER G K,LUEVANO J J,et al.Diet dominates host genotype in shaping the murine gut microbiota[J].Cell Host Microbe,2015,17(1):72-84.
[12] GOODRICH J K,WATERS J L,POOLE A C,et al.Human genetics shape the gut microbiome[J].Cell,2014,159(4):789-799.
[13] BEAUMONT M,GOODRICH J K,JACKSON M A,et al.Heritable components of the human fecal microbiome are associated with visceral fat[J].Genome Biol,2016,17(1):189.
[14] KNIGHTS D,SILVERBERG M S,WEERSMA R K,et al.Complex host genetics influence the microbiome in inflammatory bowel disease[J].Genome Med,2014,6(12):107.
[15] RIDAURA V K,FAITH J J,REY F E,et al.Gut microbiota from twins discordant for obesity modulate metabolism in mice[J].Science,2013,341(6150):1241214.
[16] XIE H,GUO R,ZHONG H,et al.Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome[J].Cell Syst,2016,3(6):572-584.
[17] LAHTI L,SALONEN A,KEKKONEN R A,et al.Associations between the human intestinal microbiota,Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data[J].Peer J,2013,1:e32.
[18] MILLION M,ANGELAKIS E,MARANINCHI M,et al.Correlation between body mass index and gut concentrations of Lactobacillus reuteri,Bifidobacterium animalis,Methanobrevibacter smithii and Escherichia coli[J].Int J Obes (Lond),2013,37(11):1460-1466.
[19] ROTH G A,FOROUZANFAR M H,MORAN A E,et al.Demographic and epidemiologic drivers of global cardiovascular mortality[J].N Engl J Med,2015,372(14):1333-1341.
[20] JACKEL S,KIOUPTSI K,LILLICH M,et al.Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2[J].Blood,2017,130(4):542-553.
[21] ZHU W,GREGORY J C,ORG E,et al.Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J].Cell,2016,165(1):111-124.
[22] ASCHER S,REINHARDT C.The gut microbiota - an emerging risk factor for cardiovascular and cerebrovascular disease[J].Eur J Immunol,2018, 48(4):564-575.
[23] KOETH R A,WANG Z,LEVISON B S,et al.Intestinal microbiota metabolism of L-carnitine,a nutrient in red meat,promotes atherosclerosis[J].Nat Med,2013,19(5):576-585.
[24] SPADONI I,ZAGATO E,BERTOCCHI A,et al.A gut-vascular barrier controls the systemic dissemination of bacteria[J].Science,2015,350(6262):830-834.
[25] BALMER M L,SLACK E,de GOTTARDI A,et al.The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota[J].Sci Transl Med,2014,6(237):237r-266r.
[26] SABATINO A,REGOLISTI G,BRUSASCO I,et al.Alterations of intestinal barrier and microbiota in chronic kidney disease[J].Nephrol Dial Transplant,2015,30(6):924-933.
[27] VAZIRI N D,WONG J,PAHL M,et al.Chronic kidney disease alters intestinal microbial flora[J].Kidney Int,2013,83(2):308-315.
[28] WONG J,PICENO Y M,DESANTIS T Z,et al.Expansion of urease- and uricase-containing,indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD[J].Am J Nephrol,2014,39(3):230-237.
[29] GREGORY J C,BUFFA J A,ORG E,et al.Transmission of atherosclerosis susceptibility with gut microbial transplantation[J].J Biol Chem,2015,290(9):5647-5660.
[30] WEINGARDEN A R,CHEN C,BOBR A,et al.Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection[J].Am J Physiol Gastrointest Liver Physiol,2014,306(4):G310-G319.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 747867 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541